ArticleJournal of the National Cancer Institute2023

Suppressing c-FOS expression by G-quadruplex ligands inhibits osimertinib-resistant non-small cell lung cancer.

Kai Lu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.